Form 4: Ormat Technologies Director Exercises SARs and Sells Shares, Reducing Stake

Dafna Sharir, a Director at Ormat Technologies, Inc. (ORA), reported exercising Stock Appreciation Rights (SARs) and subsequently selling common stock, resulting in a net reduction of her beneficial ownership.

Summary

• Dafna Sharir, a Director of Ormat Technologies, Inc. (ORA), filed a Form 4 detailing multiple transactions on June 20, 2025.
• The transactions included the exercise of 1,210 Stock Appreciation Rights (SARs) with an exercise price of $76.87, expiring November 6, 2025.
• An additional 1,315 SARs with an exercise price of $67.54, expiring November 4, 2026, were also exercised.
• To cover the exercise price of the first set of SARs, 1,089 shares were disposed of to the issuer at $85.36 per share.
• For the second set of SARs, 1,035 shares were disposed of to the issuer at $85.78 per share to cover the exercise price.
• Following the first SAR exercise, 121 shares were sold in the open market at $85.67 per share.
• Following the second SAR exercise, 280 shares were sold in the open market at $85.81 per share.
• An additional 1,200 shares of common stock were sold in the open market at $85.5802 per share.
• After all reported transactions, Dafna Sharir's direct beneficial ownership in Ormat Technologies, Inc. stands at 3,238 shares.
• The net effect of these transactions was a decrease of 1,200 shares in her direct beneficial ownership.

Sentiment

Score: 5

Explanation: The sentiment is neutral. Form 4 filings are factual reports of insider transactions. While a net sale of shares occurred, it is a common event following the exercise of equity compensation and does not inherently signal a negative outlook for the company, especially given the relatively small number of shares involved.

Positives

• The director realized value from previously granted Stock Appreciation Rights (SARs), indicating a successful vesting and exercise of compensation.
• The sale prices for the shares ($85.36, $85.67, $85.78, $85.81, $85.5802) were higher than the SAR exercise prices ($76.87 and $67.54), indicating a profitable transaction for the director.

Negatives

• The net sale of 1,200 shares by a director could be interpreted by some investors as a slight reduction in insider alignment, although it is a common practice for liquidity or diversification following option/SAR exercises.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader insights into industry trends or competitive landscape. It reflects a routine compensation-related transaction by a company director.

Related Party Transactions

• The reported transactions, involving a company director exercising Stock Appreciation Rights and selling shares, constitute related party transactions.

Stakeholder Impact

• Shareholders may note the director's net sale of 1,200 shares, which slightly reduces insider ownership. However, such transactions are common for liquidity or diversification purposes following equity compensation exercises.

Key Dates

Recommendation

Keywords

Ormat Technologies, ORA, SEC Form 4, insider transaction, Stock Appreciation Rights, SARs, director share sale, beneficial ownership, equity compensation